László Virág
Cardiology and Cardiovascular Medicine · 2001–2011
A researcher in the Science corpus: 3 papers; trusts 2 researchers and is trusted by 4 researchers here, as inferred from the citation graph.
Subfields
- Cardiology and Cardiovascular Medicine — 7 citations into it; #188 of 906 by trust here, #390 by citations
- Molecular Biology — 6 citations into it
Whom László Virág trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts László Virág overall
Papers from László Virág's perspective
Ordered by how strongly the researchers László Virág trusts endorse each paper. Same corpus, a different order for every researcher.
- Alternans and spiral breakup in a human ventricular tissue model. (American Journal of Physiology. Heart and Circulatory Physiology)
- Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage (Nature)
- Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation (Nature Medicine)
- Endothelial dysfunction in diabetes (British Journal of Pharmacology)
- Mediation of Poly(ADP-Ribose) Polymerase-1-Dependent Cell Death by Apoptosis-Inducing Factor (Science)
- Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease. (Progress in neurobiology)
- Ca2+/Calmodulin-Dependent Protein Kinase II Phosphorylation Regulates the Cardiac Ryanodine Receptor (Circulation Research)
- A Novel Computational Model of the Human Ventricular Action Potential and Ca Transient (Journal of Molecular and Cellular Cardiology)
- A computational model of the human left-ventricular epicardial myocyte. (Biophysical Journal)
- A model for human ventricular tissue. (American Journal of Physiology. Heart and Circulatory Physiology)
Their papers
- Simulation of the Undiseased Human Cardiac Ventricular Action Potential: Model Formulation and Experimental Validation (2011) — 1,200 citations
- The Therapeutic Potential of Poly(ADP-Ribose) Polymerase Inhibitors (2002) — 1,416 citations
- Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation (2001) — 630 citations